Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability.

Ansaldi F, Orsi A, de Florentiis D, Parodi V, Rappazzo E, Coppelli M, Durando P, Icardi G.

Hum Vaccin Immunother. 2013 Mar;9(3):591-8. Epub 2013 Jan 7.

2.

Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccines.

Orsi A, Ansaldi F, de Florentiis D, Ceravolo A, Parodi V, Canepa P, Coppelli M, Icardi G, Durando P.

Hum Vaccin Immunother. 2013 Mar;9(3):582-90. Epub 2013 Jan 7. Review.

3.

Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review.

Camilloni B, Basileo M, Valente S, Nunzi E, Iorio AM.

Hum Vaccin Immunother. 2015;11(3):553-63. doi: 10.1080/21645515.2015.1011562. Review.

4.

Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis.

Beyer WE, Nauta JJ, Palache AM, Giezeman KM, Osterhaus AD.

Vaccine. 2011 Aug 5;29(34):5785-92. doi: 10.1016/j.vaccine.2011.05.040. Epub 2011 May 30. Review.

PMID:
21624411
5.

Intanza 15 microg intradermal seasonal influenza vaccine: in older adults (aged >or=60 years).

Duggan ST, Plosker GL.

Drugs Aging. 2010 Jul 1;27(7):597-605. doi: 10.2165/11203880-000000000-00000. Review.

PMID:
20583853
6.

Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine.

Herzog C, Hartmann K, Künzi V, Kürsteiner O, Mischler R, Lazar H, Glück R.

Vaccine. 2009 Jul 16;27(33):4381-7. doi: 10.1016/j.vaccine.2009.05.029. Epub 2009 May 29. Review.

PMID:
19450630
7.

Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system.

Icardi G, Orsi A, Ceravolo A, Ansaldi F.

Hum Vaccin Immunother. 2012 Jan;8(1):67-75. doi: 10.4161/hv.8.1.18419. Epub 2012 Jan 1. Review.

8.

Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age.

Leroux-Roels I, Weber F.

Hum Vaccin Immunother. 2013 Jan;9(1):115-21. doi: 10.4161/hv.22342. Review.

10.

Intradermal vaccination to protect against yellow fever and influenza.

Roukens AH, Gelinck LB, Visser LG.

Curr Top Microbiol Immunol. 2012;351:159-79. doi: 10.1007/82_2011_124. Review.

PMID:
21416266
11.

Intranasal immunization against influenza.

Glück R.

J Aerosol Med. 2002 Summer;15(2):221-8. Review.

PMID:
12184872
12.

Sex-based biology and the rational design of influenza vaccination strategies.

Klein SL, Pekosz A.

J Infect Dis. 2014 Jul 15;209 Suppl 3:S114-9. doi: 10.1093/infdis/jiu066. Review.

13.

Making evidence-based selections of influenza vaccines.

Childress BC, Montney JD, Albro EA.

Hum Vaccin Immunother. 2014;10(9):2729-32. doi: 10.4161/hv.29340. Epub 2014 Nov 19. Review.

14.

Influenza vaccination: options and issues.

Wong SS, Yuen KY.

Hong Kong Med J. 2005 Oct;11(5):381-90. Review.

Supplemental Content

Support Center